Pharming Group NV Cash Flow-to-Debt Ratio
Pharming Group NV cash flow-to-debt ratio. Pharming Group NV (PHARM) has a Cash Flow-to-Debt Ratio of 0.15x as of September 2025, meaning its operating cash flow of €32.03 Million could theoretically repay 0% of its total liabilities (€209.14 Million) in one year. Check Pharming Group NV cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Pharming Group NV (2005–2024)
Cash flow-to-debt ratio of Pharming Group NV from 2005 to 2024. Historical debt coverage capacity for Pharming Group NV across 20 annual periods. Check PHARM capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Pharming Group NV Cash Flow-to-Debt Ratio by Year (2005–2024)
Pharming Group NV cash flow-to-debt ratio by year from 2005 to 2024. Year-by-year debt coverage analysis for Pharming Group NV. For the full cash flow conversion analysis, see PHARM cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.01x | €-1.79 Million | €172.72 Million | ▲ +87.9% |
| 2023 | -0.09x | €-19.55 Million | €228.28 Million | ▼ -182.7% |
| 2022 | 0.10x | €22.90 Million | €221.16 Million | ▼ -41.5% |
| 2021 | 0.18x | €36.13 Million | €204.19 Million | ▼ -54.2% |
| 2020 | 0.39x | €90.98 Million | €235.39 Million | ▼ -28.3% |
| 2019 | 0.54x | €74.56 Million | €138.38 Million | ▲ +103.9% |
| 2018 | 0.26x | €46.19 Million | €174.81 Million | ▲ +1.9% |
| 2017 | 0.26x | €45.84 Million | €176.82 Million | ▲ +357.4% |
| 2016 | -0.10x | €-10.52 Million | €104.45 Million | ▲ +79.2% |
| 2015 | -0.49x | €-17.95 Million | €37.00 Million | ▼ -137.9% |
| 2014 | -0.20x | €-6.42 Million | €31.46 Million | ▲ +35.1% |
| 2013 | -0.31x | €-11.45 Million | €36.45 Million | ▲ +25.1% |
| 2012 | -0.42x | €-13.58 Million | €32.40 Million | ▲ +30.9% |
| 2011 | -0.61x | €-20.34 Million | €33.55 Million | ▼ -218.4% |
| 2010 | -0.19x | €-6.89 Million | €36.16 Million | ▲ +57.4% |
| 2009 | -0.45x | €-27.24 Million | €60.99 Million | ▼ -138.7% |
| 2008 | -0.19x | €-14.21 Million | €75.96 Million | ▲ +31.4% |
| 2007 | -0.27x | €-31.69 Million | €116.14 Million | ▲ +59.3% |
| 2006 | -0.67x | €-25.89 Million | €38.59 Million | ▲ +69.5% |
| 2005 | -2.20x | €-15.26 Million | €6.93 Million | — |